Literature DB >> 35213668

Progress towards controlling the HIV epidemic in urban Ethiopia: Findings from the 2017-2018 Ethiopia population-based HIV impact assessment survey.

Sileshi Lulseged1, Zenebe Melaku1, Abebe Habteselassie2, Christine A West3, Terefe Gelibo1, Wudinesh Belete2, Fana Tefera4, Mansoor Farahani5, Minilik Demissie2, Wondimu Teferi4, Saro Abdella2, Sehin Birhanu3, Christine E Ross4.   

Abstract

INTRODUCTION: In 2014, the Joint United Nations Programme on HIV/AIDS set an 'ambitious' 90-90-90 target for 2020. By 2016, there were disparities observed among countries in their progress towards the targets and some believed the targets were not achievable. In this report, we present the results of data from the Ethiopia Population-based HIV Impact Assessment survey analyzed to assess progress with the targets and associated factors.
METHODS: We conducted a nationally representative survey in urban areas of Ethiopia. Socio-demographic and behavioural data were collected from consenting participants using a structured interview. HIV testing was done following the national HIV rapid testing algorithm and seropositivity confirmed using a supplemental laboratory assay. HIV viral suppression was considered if the viral load was <1,000 RNA copies/ml. Screening antiretroviral drugs was done for efavirenz, lopinavir, and tenofovir, which were in use during the survey period. In this analysis, we generated weighted descriptive statistics and used bivariate and logistic regression analysis to examine for associations. The 95% confidence interval was used to measure the precision of estimates and the significance level set at p<0.05.
RESULTS: Of 19,136 eligible participants aged 15-64 years, 614 (3% [95% CI: 0.8-3.3]) were HIV-positive, of which 79.0% (95% CI: 4.7-82.7) were aware of their HIV status, and 97.1% (95% CI: 95.0-98.3 were on antiretroviral therapy, of which 87.6% (95% CI: 83.9-90.5) achieved viral load suppression. Awareness about HIV-positive status was significantly higher among females (aOR = 2.8 [95% CI: 1.38-5.51]), significantly increased with age, the odds being highest for those aged 55-64 years (aOR = 11.4 [95% CI: 2.52-51.79]) compared to those 15-24 years, and was significantly higher among those who used condom at last sex in the past 12 months (aOR = 5.1 [95% CI: 1.68-15.25]). Individuals with secondary education and above were more likely to have achieved viral suppression (aOR = 8.2 [95% CI: 1.82-37.07]) compared with those with no education.
CONCLUSION: Ethiopia made encouraging progress towards the UNAIDS 90-90-90 targets. The country needs to intensify its efforts to achieve the targets. A particular focus is required to fill the gaps in knowledge of HIV-positive status to increase case identification among population groups such as males, the youth, and those with low education.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35213668      PMCID: PMC8880883          DOI: 10.1371/journal.pone.0264441

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

In 2014, the Joint United Nations Programme on HIV/AIDS launched the ambitious 90-90-90 treatment targets to end the HIV pandemic by 2020; the aim was to diagnose 90% of all HIV-positive persons, provide antiretroviral treatment (ART) to 90% of those diagnosed, and achieve viral suppression in 90% of those treated [1]. When these treatment targets were achieved, at least 73% (90*90*90) of all people living with HIV (PLHIV) worldwide would achieve viral load suppression (VLS). Modelling suggested that achieving these targets by 2020 would enable the world to continue with actions that will end the HIV/AIDS epidemic by 2030, which in turn would generate profound health and economic benefits [1, 2]. The targets were widely promoted and adopted by countries and international implementing partners [3]. By 2020, though only a few countries had taken sufficient action to achieve the targets, much of the complex reality of the HIV epidemic was increasingly understood and countries were in a better position to identify gaps and develop strategies to reach PLHIV who were left behind [4]. A comprehensive approach would be required to fill the gaps and achieve the next set of UNAIDS 95-95-95 testing and treatment targets; 95% of people living with HIV know their HIV status, 95% of PLHIV who know their status are on treatment, and 95% of people on treatment have suppressed viral loads, thereby reducing the annual number of new HIV infections among adults to 200,000 or fewer; and achieving zero discrimination by 2030 [5]. Ethiopia introduced a large-scale ART programme in 2005 and made remarkable progress by 2016 in reducing the prevalence of HIV infection from 1.4% to 0.9% and the number of AIDS-related deaths from 83,000 to 15,600 [6]. The country achieved a 50% reduction in HIV incidence rate and a decline in HIV mortality rate, reaching a tipping point (the incidence mortality ratio, where the number of new infections drops below the number of deaths) [7]. However, after the remarkable decline in the incidence and prevalence of HIV infection in all age groups, progress started to slow down in the last few years. Ethiopia was not able to fully achieve the 90-90-90 targets due to several barriers [8]. Economic constraints, perceived stigma and discrimination, fasting, holy water, medication side effects, and dissatisfaction with healthcare services were major reasons for non-adherence and interruption of treatment among PLHIV [9]. Isolated studies also showed that treatment failure is an emerging barrier that is associated with transmission of drug-resistant HIV strains at the population level [10]. Reports on HIV care and treatment services were primarily drawn from the Ethiopian demographic and health survey (EDHS),supplemented by data from routine antenatal sentinel surveillance, programme monitoring, mathematical modeling, and special studies in tracking the magnitude and dynamics of the HIV epidemic. There were no national-level, population-based studies conducted in Ethiopia, which measured ART coverage and VLS. Reliable nationally representative data for HIV programming was lacking. Therefore, as part of a multi-country population-based HIV impact assessment (PHIA) project, the government of Ethiopia spearheaded the Ethiopia population-based HIV impact assessment (EPHIA) survey to measure the Ethiopia’s national response to the epidemic, assess the coverage and impact of HIV services, and measure HIV-related risk behaviors. We are reporting here the results of an analysis of EPHIA survey data, focusing on the progress made towards the UNAIDS 90–90–90 targets and associated factors to inform the national policy and HIV programming that will help the country achieve the 95-95-95 targets.

Materials and methods

The survey protocol was approved by the institutional review boards of the Ethiopian Research Institute, Addis Ababa (EPHI-IRB-028-2017), Columbia University, City of New York, USA (IRB-AAAR5279), and US Centers for Disease Control and Prevention, Atlanta, USA (Protocol #7044).

Survey setting and population

Ethiopia is the second-most populous country in Africa and is divided into nine regional states and two city administrations. Projections from the 2007 housing and population census estimated the total population for the year 2017 at 105 million and the breakdown by age showed that 47% of the population were under 15 years of age, 49% between 15 and 64 years, and 4% were 64 years and above [11]. The median age was 16.8 years and the population growth rate estimated at 2.6%, the eighth highest in the world [12]. In the EPHIA survey, geographic classification followed the 2007 National Population and Housing Census, which included all capitals of the nine regional states and the two city administrations, zones, and woredas (districts) where inhabitants were primarily engaged in non-agricultural activities [13]. Only 25% of Ethiopia’s population resided in urban areas, but population density and consequently the density of HIV infection were high in these parts of the country [14]. HIV prevalence was very low and HIV cases were thinly spread out across the rural areas, which constitute over 80% of the landmass of the country [7]. Consequently, we conducted the EPHIA survey in urban Ethiopia.

Study design

The EPHIA was a household (HH)-based survey conducted among urban adults 15–64 years and children 0–14 years of age. The survey employed the methods used by the multi-country population-based HIV impact assessment (PHIA) survey conducted in other 14 African countries [15]. The details of the design, methods, and tools (including the original English version of the questionnaire) are available in the survey report on the ICAP Columbia University website [16]. The sample size was powered to provide estimates of national and regional levels of VLS among HIV positive adults. All adult HH members were included in the HH rosters compiled for sampling purposes. The selection of participants involved compiling a list of all individuals known to reside in the HH or who slept in the HH during the night prior to data collection, identifying rostered individuals who were eligible for data collection, selecting those meeting the age and residency requirements of the study.

Data collection

The data were collected from October 2017 to April 2018. Questionnaire and field laboratory data were collected on mobile Google Nexus 9 tablets. The adult questionnaires were administered in Amharic, Oromiffa, Tigrigna, Afarigna, and Somaligna (the five languages commonly used in Ethiopia) to all eligible participants aged 15 years and older through face-to-face interviews. The data included demographic, behavioural, and clinical information and participants’ self-reported knowledge of HIV and treatment status. Home-based HIV rapid testing was done using the Ethiopian national HIV rapid testing algorithm and CD4 T-cell counts determined on PIMA machine. Laboratory evaluation also included Geenius confirmatory testing, plasma ARV drugs, and genotyping for HIV transmitted drug resistance mutations done at the central level by the Ethiopian Public Health Institute (EPHI). Samples from all confirmed HIV-positive participants were evaluated for the presence of three ARVs (efavirenz, lopinavir, and tenofovir), which were selected as markers for the most prescribed first- and second-line regimens in use at the time of the survey. Samples from participants who had suppressed viral loads and/or reported being on ART, but had no evidence of the first three compounds, were tested for nevirapine.

Data analysis

The 90-90-90 target achievements in this analysis were based on self-reports adjusted for ARV drug detection. ‘Awareness’ and ‘being on treatment’ were adjusted such that individuals with detected ARVs were classified as ‘aware’ (first 90) and ‘on treatment’ (second-90) even if they did not self-report knowing their HIV-positive status or being on ART. The achievements for the second-90 were expressed either as conditional (proportion on treatment among those who were aware) or unconditional (proportion on treatment among all positives). For the third-90, achievements were expressed as conditional (proportion with viral suppression among those on treatment) or unconditional (proportion with viral suppression among all positives). Overall, HIV-positive participants who were aware of their HIV status, receiving ART, and had HIV-1 RNA <1000 copies per mL were considered to have VLS. Overall cascade response was compared against the UNAIDS cascade response of 73% (i.e. 90*90*90). The results of the analysis reported here are weighted estimates unless otherwise stated. The weighting accounted for sample selection probabilities adjusted for non-response and non-coverage. Non-response adjusted weights were calculated for HHs, individual interviews, and individual blood draws in a hierarchical manner. Nonresponse adjustments for the initial individual and blood-level weights were based on the development of weighting adjustment cells defined by a combination of variables that are potential predictors of response and HIV status. The weighted estimates were produced by using the Jackknife replication, a method that estimates the variance/standard and bias of a large population sample data by involving a leave-one-out strategy of the estimation of a parameter in a dataset [17] done on Stata 14 [18]. We generated weighted descriptive statistics for the variables and included in the analysis and determined the association between the explanatory and outcome variables using a bivariate analysis with Chi-square statistic to test for significance of the association between categorical variables. Multiple logistic regression was employed to examine for an independent association between explanatory variables and the target outcomes. Variables with p-value of 0.2 in the bivariate analysis were selected for the multivariate regression analysis. The 95% confidence interval was used to measure the precision of point estimates and a p-value of <0.05 considered statistically significant.

Ethical considerations

The survey team informed all potential participants that participation was voluntary and that they did not need to disclose personal information, which they were uncomfortable sharing, and that they could withdraw from the survey at any time. The team also provided to all potential participants a printed copy of the consent form in one of the six survey languages depending upon their preference prior to initiation of any survey procedures. For illiterate participants, an impartial witness chosen by the participant was involved. Potential participants who did not speak any of the six survey languages were considered ineligible. A designated HH head provided written consent for HH members to participate in the survey, after which individual members were rostered during a HH interview. Consent was then obtained from participants aged 18–64 years who were willing and able to provide written consent for the interview and biomarker components of the survey, including home-based testing and counselling with the return of HIV-test results. Emancipated minors constituting participants aged 13–17 years and were working or earning their living, married, or parenting [19] provided the written consent like the age group 18–64 years. The waiver of parental/guardian consent for the emancipated minors was given as part of the protocol approval by the institution review boards. Survey teams ensured that written parental/guardian permission was obtained for assenting minors aged 15–17 years. At each stage of the process, the participant indicated consent by signing or making a mark on the consent form on the tablet and in a printed copy, which was retained by the participant. Receipt of tests results was a requirement for participation in the biomarker component.

Results

Participants’ characteristics

A total of 21,560 eligible adults aged 15–64 years was identified from among 25,416 adult HH members who were randomly selected proportional to the population structure from among 11,841 HH in 393 randomly selected enumeration areas (EAs) (Fig 1). Of a total of 25,416 adults >15 years and above rostered during the HH interview, 21, 560 were eligible, of which 20,170 (12,158 females and 8,012 males) were interviewed and 19,136 (11,599 females and 7,537 males) had blood specimens drawn for biomarker testing. Of 3,856 (6.4%) HH members who were not eligible, 2,516 were not in the HH during the previous night, 1,338 were excluded because of age over 64 years, cognitive impairment or intellectual disability, language and other reasons, and only two were rostered in error.
Fig 1

Sampling flow chart, Ethiopia population-based HIV impact assessment survey 2017–2018.

Most of the participants (92.9%) were from the Oromia, Amhara, Addis Ababa, SNNPR and Tigray regions (Table 1). Over two-thirds (67.9%) of them were female and 34.9% were in the age group 5 to 24 years. Participants who were married or living together constituted 52.1%, those who had primary education 35.5%, and those not employed in the past 12 months 52.9%. A majority (95.0%) had first sex after 15 years of age, and about two-thirds (68.2%) had one sexual partner in the last 12 months prior to the survey, 65.2% did not use a condom at last sex in the past 12 months and 70.5% reported ever being tested for HIV.
Table 1

HIV prevalence by socio-demographic and behavioural characteristics among participants aged 15–64 years, Ethiopia population-based HIV impact assessment, 2017–2018.

CharacteristicsN (Weighted %)HIV Infection StatusP-value
PositiveNegative
nWeighted % (95% CI)nWeighted % (95% CI)
Administrative Region
Tigray1,369 (7.5%)392.7 (1.9–3.6)1,33097.3 (96.4–98.1)<0.0001
Afar821 (1.3%)324.1 (2.9–5.8)78995.9 (94.2–97.1)
Amhara2,999 (18.2%)1184.1 (3.4–5.0)2,88195.9 (95.0–96.6)
Oromia4,510 (34%)1493.0 (2.5–3.6)4,36197.0 (96.4–97.5)
Somali926 (1.3%)80.8 (0.4–1.6)91899.2 (98.4–99.6)
Benishangul Gumuz798 (1.3%)202.4 (1.6–3.8)77897.6 (96.2–98.4)
SNNPR2,665 (16.2%)491.8 (1.3–2.4)2,61698.2 (97.6–98.7)
Gambella788 (0.6%)445.7 (4.2–7.7)74494.3(92.3–95.8)
Harari697 (0.7%)324.6 (3.3–6.5)66595.4 (93.5–96.7)
Addis Ababa2,780 (17.7%)883.1 (2.5–3.8)2,69296.9 (96.2–97.5)
Dire Dawa783 (1.2%)354.6 (3.3–6.5)74895.4 (93.5–96.7)
Total19,1366143.0 (2.8–3.3)18,52297.0 (96.7–97.2)
Sex
Female11,599 (50.5%)4614.1 (3.7–4.5)11,13895.9 (95.5–96.3)<0.0001
Male7,537 (49.5%)1531.9 (1.6–2.3)738498.1 (97.7–98.4)
Total19,1366143.0 (2.8–3.3)18,52297.0 (96.7–97.2)
Age group
15–24 years7,547 (34.9%)620.7 (0.5–1.0)7,48599.3 (99.0–99.5)<0.0001
25–34 years5,664 (30.3%)1752.6 (2.2–3.1)5,48997.4 (96.9–97.8)
35–44 years3,136 (18.9%)2346.2 (5.4–7.2)2,90293.8 (92.8–94.6)
45–54 years1,651 (10.1%)1046.1 (4.9–7.5)1,54793.9 (92.5–95.1)
55–64 years1,138 (5.8%)393.4 (2.4–4.7)1,09996.6 (95.3–97.6)
Total19,1366143.0 (2.8–3.3)18,52297 (96.7–97.2)
Marital status 
Never married7,103 (35.5%)711.0 (0.7–1.3)7,03299.0 (98.7–99.3)0.0001
Married or living together9,418 (52.1%)2852.8 (2.4–3.2)9,13397.2 (96.8–97.6)
Divorced or separated1,723 (8.5%)1447.7 (6.5–9.3)1,57992.3 (90.7–93.5)
Widowed7,72 (3.9%)11214.7 (12.1–17.7)66085.3 (82.3–87.9)
Total19,0166123.0 (2.8–3.3)18,40497 (96.7–97.2)
Education level 
No education2,004 (11.9%)1215.2 (4.2–6.3)2,27994.8 (93.7–95.8)<0.0001
Primary6,803 (35.5%)2914.2 (3.7–4.8)6,51295.8 (95.2–96.3)
Secondary5,488 (28.7%)1412.4 (2.0–2.9)5,34797.6 (97.1–98.0)
More than secondary4,376 (24%)581.0 (0.7–1.4)4,31899.0 (98.6–99.3)
Total19,0676113.0 (2.8–3.3)18,45697 (96.7–97.2)
Employment status in the last 12 months
Did not worked313 (49.4)3132.8 (2.5–3.2)1064297.2 (96.8–97.5) 
Worked 12 last months298 (50.6)2983.2 (2.8–3.7)7,85696.8 (96.3–97.2)0.158
Total19,1096113.0 (2.8–3.3)18,49897.0 (96.7–97.2) 
Number of sexual partners in the past 12-months
None3,689 (27.7)2416.0 (5.2–6.9)3,44894.0 (93.1–94.8)<0.0001
One partner8,778 (68.2)2702.9 (2.5–3.3)8,50897.1 (96.7–97.5)
Two or more partners497(4.1)253.1 (2.0–5.0)47296.9 (95.0–98.0)
Total12,9645363.8 (3.4–4.1)12,42896.2 (95.9–96.6)
Gender of household head
Male headed HH9,343 (53.7%)2132.2 (1.9–2.6)9,13097.8 (97.4–98.1)<0.0001
Female Headed Households9,793 (46.3%)4014.0 (3.6–4.5)9,39296.0 (95.5–96.4)
Total19,1366143.0 (2.8–3.3)18,52297.0 (96.7–97.2)
Food insecurity in the past 4 weeks
No18,223 (95.5%)5522.9 (2.7–3.2)17,67197.1 (96.8–97.3)<0.0001
Yes808 (4.5%)565.0 (3.7–6.8)75295.0 (93.2–96.3)
Total19,0316083.0 (2.8–3.3)18,42397.0 (96.7–97.2)
First sex before age 15
First sex 15 + years17,735 (95.0%)5362.9 (2.6–3.1)17,19997.1 (96.9–97.4)<0.0001
First sex before 151,014 (5.0%)706.8 (5.3–8.7)94493.2 (91.3–94.7)
Total18,749606 18,143  
Condom use at last sex in the past 12 months
Used793 (6.4%)839.6 (7.5–12.2)71090.4 (87.8–92.5)<0.0001 
Did not use8,192 (65.2%)2032.3 (2.0–2.7)7,98997.7 (97.3–98.0)
No sex3,689 (28.4%)2416.0 (5.2–6.9)3,44894.0 (93.1–94.8)
Total12,6745273.1 (2.8–3.3)12,14796.9 (96.7–97.2)
Ever tested for HIV
Never tested5740 (29.5%)511.0 (0.7–1.3)5,68999.0 (98.7–99.3) 
Ever tested13.186 (70.5%)5613.9 (3.6–4.3)12,62596.1 (95.7–96.4)<0.0001
Total (N) 19,136 614 3.0 (2.8–3.3) 18,522 97.0 (96.7–97.2)  

HIV prevalence

Of the 19,136 participants who were tested for HIV, 614 tested positive, an overall HIV prevalence of 3% (95% CI: 2.8–3.3), which varied by region from 0.8% (95% CI: 0.4–1.6) in Somali to 5.7% (95% CI: 4.2–7.7) in Gambella (p<0.0001). The prevalence was significantly higher among females than males (4.1% [95% CI: 3.7–4.5]) vs 1.9% (95% CI: 1.6–2.3) (p<0.0001) and was higher (6.2% [95% CI: 5.4–7.2]) in the age group 35–44 years, among those who were widowed (14.7% [95%CI = 12.1–17.7]), those with no formal education (5.2% [95% CI: 4.2–6.3]), female-headed HHs (4.0% [95% CI: 3.6–4.5]), and food-insecure (5.0% [95% CI: 3.7–6.8]) than in the other the categories in their respective groups. The prevalence was also higher among those who had first sexual exposure before age of 15 years (6.8% [95% CI: 5.3–8.7]), had no sexual partner in the past 12 months (6.0% [95% CI: 5.2–6.9]), and those who used condom in the past 12 months (9.6% [95% CI: 7.5–12.2]). The differences in HIV prevalence across the various strata of the above variables were statistically significant (p<0.0001).

Progress towards UNAIDS 90-90-90 targets and associated factors

Data on awareness about HIV positive status, ART (based on ARV drugs testing), and achievement of VL suppression was available for 609 (99.2%) of the 614 HIV-positive participants. In terms of the unconditional UNAIDS targets, 79% were aware of their HIV status, 77% of were on ART and 67% had suppressed viral loads (Fig 2). Among those aged 15–24 years, VLS achievement was much lower (46.8%).
Fig 2

Achievements of unconditional UNAIDS 90-90-90 targets among participants aged 15–64 years in urban Ethiopia, Ethiopia population-based HIV impact assessment, 2017–2018 (n = 609).

Details of Ethiopia’s progress in achieving each of the cascade UNAIDS 90-90-90 targets by 2018 are summarized in Table 2.
Table 2

Association of socio-demographic and behavioural characteristics with the 90-90-90 targets among participants aged 15–64 years, Ethiopia Population-based HIV impact assessment, 2017–2018.

CharacteristicsAwareness of HIV Positive StatusOn Antiretroviral TreatmentAchieved Viral Suppression
nWeighted % (95%CI)nConditional weighted % (95%CI)nConditional weighted % (95%CI)
Region
Tigray3889.5 (74.7–96.1)341003478.3 (60.8–89.3)
Afar3275.1 (57.1–87.2)241002486.4 (64.7–95.7)
Amhara11885.2 (76.2–91.2)10310010392.1 (84.5–96.2)
Oromia14876.0 (67.2–83.0)11995.2 (89.7–97.9)11389.6 (82.7–94.0)
Somali81008100890.0 (52.4–98.7)
Benishangul Gumuz2094.2 (68.3–99.2)191001996.4 (78.1–99.5)
SNNPR4973.3 (58.9–84.1)3694.4 (80.0–98.6)3485.2 (68.6–93.9)
Gambella4466.6 (50.9–79.3)3092.0 (72.8–98.0)2888.4 (69.5–96.2)
Harari3273.3 (55.5–85.7)231002388.1 (68.2–96.3)
Addis Ababa8674.8 (64.0–83.2)6595.2 (87.7–98.3)6180.2 (68.2–88.4)
Dire Dawa3483.9 (66.3–93.2)291002988.0 (71.6–95.5)
Sex
Female45683.3 (79.0–86.9)*37896.4 (93.5–98.0)36686.1 (81.7–89.6)
Male15370.0 (60.6–78.1)11298.9 (94.1–99.8)11091.1 (83.0–95.6)
Age group
15–24 years6263.0 (48.1–75.8)391003974.3 (54.9–87.3)
25–34 years17279.9 (70.8–86.7)14195.8 (90.3–98.2)13582.8 (74.0–89.1)
35–44 years23379.2 (71.9–85.1)19096.7 (92.5–98.6)18489.4 (83.5–93.3)
45–54 years10482.2 (72.4–89.1)8798.9 (92.4–99.8)8692.7 (84.7–96.7)
55–64 years3885.5 (69.2–94.0)3395.8 (75.5–99.4)3292.7 (77.7–97.9)
Marital status
Never married7176.2 (63.0–85.8)5397.8 (86.1–99.7)5276.9 (62.4–87.0)
Married/living together28576.9 (70.1–82.6)22897.2 (93.6–98.8)22192.5 (87.8–95.5)
Divorced or separated14080.3 (71.1–87.2)11497.7 (93.1–99.3)11188.4 (80.1–93.5)
Widowed11184.9 (75.5–91.1)9495.8 (87.7–98.7)9183.1 (72.9–90.0)
Education
No education12086.2 (77.2–92.0)10195.2 (87.9–98.2)9683.6 (73.9–90.2)
Primary28876.2 (69.5–81.9)23098.3 (95.5–99.4)22687.8 (82.2–91.8)
Secondary14181.9 (73.2–88.2)11795.7 (89.1–98.4)11387.2 (78.6–92.7)
More than secondary5771.3 (54.6–83.7)4099.4 (95.5–99.9)3998.8 (95.2–99.7)
Gender of head of household
Male headed HHs21371.9 (63.8–78.7)16197.8 (93.9–99.2)15691.4 (85.4–95.0)
Female headed HHs39683.6 (78.9–87.5)*32996.7 (93.7–98.3)32085.5 (80.5–89.3)
Condom use at last sex in the past 12 months
Used condom8391.3 (82.2–96.0)7598.6 (90.6–99.8)7493.6 (84.7–97.5)
Did not use condom20170.0 (61.4–77.3)15095.4 (90.2–97.9)14291.1 (84.7–95.0)
No sex, past 12 months23882.2 (75.4–87.4)19997.5 (93.4–99.1)19586.0 (79.7–90.6)
Total60979.0 (74.7–82.7)49097.1 (95.0–98.3)47687.6 (83.9–90.5)

* Statistically significant (nonoverlapping of confidence intervals)

* Statistically significant (nonoverlapping of confidence intervals)

Awareness status (first 90)

Among HIV-positive adults (79.0% [95% CI: 74.7–82.7]) were aware of their positive status when adjusted for ARV detection. Weighted awareness of HIV-positive status was high for the Benishangul Gumuz and Tigray regions (94.2% [95% CI: 68.3–99.2]) and (89.5% [95% CI: 74.7–96.1]), respectively, and the lowest, (66.6% [95% CI: 50.9–79.3]) for Gambella. There was a significant difference by gender (83.3% [95% CI 79.0–86.9]) in females vs (70.0% [95% CI: 0.6–78.1]) in males and by gender of the HH head (83.6% [95% CI: 78.9–87.5]) female-headed vs (71.9% [95% CI: 63.8–78.7) male-headed.

Treatment status (second 90)

Based on both self-reported ART status and detection of ARVs in their blood (97.1% [95% CI: 95.0–98.3]) of those aware of their status were on ART. Though there were some numerical differences in the association between the second 90 and administrative region, sex, and age, the differences were not statistically significant. The proportion of those on ART ranged from 92.0% (95% CI: 72.8–98.0) in Gambella to 100% in most of the regions and was above 95.4% across categories by sex, age, marital status, gender of head of HH, and condom use at the last sex in the past 12 months.

VLS (third 90)

Among adults on ART (87.6% [95% CI: 83.9–90.5]) had VLS, ranging from (74.3% [95% CI: 54.9–87.3]) among the youth to (92.7% [95% CI: 77.7–97.9]) among older adults ages 50–64. Across all age groups, there was no statistically significant difference in VLS among females and males on ART. Though there were differences in the association between the third 90 and administrative region, and sex, and age, these did not achieve statistically significance. For VLS, the proportion ranged from 78.3% (95% CI: 60.8–89.3) in Tigray to 96.4% (95% CI: 78.1–99.5) in the Benishangul Gumuz region, similarly high in both sex groups, and low (74.3% [95% CI: 54.9–87.3]) in the age group 15–24 years. As shown in Fig 3, females performed better in the first and third 90 targets. Awareness was higher among those aged 25 years and older (>79.2%) compared to those15-24 years (63.0%) (Fig 4).
Fig 3

ARV adjusted conditional 90-90-90 targets achieved among adult participants by sex, Ethiopia population-based HIV impact assessment, 2017–2018.

Fig 4

ARV adjusted conditional 90-90-90 targets achieved among adult participants by age, Ethiopia population-based HIV impact assessment, 2017–2018.

The results of a multivariate logistic regression analysis of the independent variables on HIV-positive status awareness and conditional estimates of having achieved VLS are given along with the adjusted odds ratios (aOR) in Table 3. Participants’ sex, age, and condom use were independently and significantly associated with awareness about HIV-positive status. Females were more likely to be aware of their HIV-positive status (aOR = 2.8 [95% CI: 1.38–5.51]) as compared to males. The odds of being aware of HIV-positive-status was significantly higher with increasing age, (aOR = 4.2 [95% CI: 1.50–11.91]) for those 25 to 34-years. (aOR = 5.5 [95% CI: 2.03–15.01]) for those 35 to 44 years, (aOR = 7.0 [95% CI: 1.95–24.87]) for those 45 to 54 years, and (aOR = 11.4 [95% CI: 2.52–51.79]) for those 55 to 64 years compared to the youth 15–24 years of age. Participants who used condoms at last sex in the past 12 months were more likely to be aware of their HIV- positive status (aOR = 5.1 [95% CI: 1.68–15.25]), compared to those who did not use condom. VLS was strongly and significantly associated with increasing educational status; individuals with secondary education and above were more likely to have achieved viral suppression (aOR = 8.2 [95% CI: 1.82–37.07]) compared with those with no education.
Table 3

Factors associated with HIV positive awareness among people living with HIV and viral load suppression among HIV positive adult participants, Ethiopia population-based HIV impact assessment, 2017–2018*.

CharacteristicsAware of HIV+ statusVirally suppressed
among people living with HIVamong HIV+ participants on ART
AOR (95%CI)P-valueAOR (95%CI)P-value
Region
Tigray2.4 (0.32–18.56)0.3920.7 (0.17–3.12)0.660
Afar1.0 (0.14–6.99)0.9821.2 (0.23–6.85)0.801
Amhara1.2 (0.18–8.26)0.8333.4 (0.65–18.22)0.144
Oromia0.7 (0.13–4.33)0.7331.8 (0.37–8.35)0.478
Benishangul Gumuz5.6 (0.61–51.67)0.1282.8 (0.71–11.24)0.140
SNNPR1.1 (0.14–8.0)0.9600.8 (0.13–5.24)0.836
Gambella1111
Harari0.4 (0.05–3.61)0.4370.7 (0.14–3.56)0.671
Addis Ababa0.5 (0.09–3.37)0.5111.0 (0.22–4.32)0.961
Dire Dawa1.0 (0.15–7.21)0.9651.0 (0.17–6.31)0.975
Sex
Female2.8** (1.38–5.51)0.0040.7 (0.15–3.43)0.680
Male1111
Age group
15–24 years1111
25–34 years4.2** (1.50–11.91)0.0071.3 (0.14–11.90)0.816
35–44 years5.5** (2.03–15.01)0.0012.0 (0.22–18.23)0.545
45–54 years7.0** (1.95–24.87)0.0032.1 (0.20–21.49)0.536
55–64 years11.4** (2.52–51.79)0.0024.8 (0.12–192.89)0.404
Marital status
Never married1111
Married or living together1.0 (0.35–2.56)0.9233.4 (0.75–15.37)0.112
Divorced or separated0.7 (0.26–1.97)0.5103.9* (0.80–18.83)0.092
Widowed1.1 (0.35–3.15)0.9222.2 (0.52–8.96)0.284
Gender of head of household
Male headed HH1111
Female Headed Households1.2 (0.60–2.43)0.5930.9 (0.29–2.78)0.841
Education level
No education1111
Primary0.9 (0.44–1.86)0.7921.5 (0.62–3.4030.384
Secondary1.4 (0.59–3.08)0.4741.9 (0.58–6.10)0.288
More than secondary0.8 (0.283–2.01)0.5718.2** (1.82–37.07)0.006
Condom use at last sex in the past 12 months
Used condom5.1** (1.68–15.25)0.0041.4 (0.36–5.77)0.605
Did not use condom1111
No sex in the past 12 month1.5 (0.70–3.0)0.3140.8 (0.37–1.89)0.656

* Antiretroviral treatment (ART) not included here as achievement is more than 98%

** Statistically significant (p<0.05)

* Antiretroviral treatment (ART) not included here as achievement is more than 98% ** Statistically significant (p<0.05)

Discussion

The HIV prevalence estimate from EPHIA was similar to urban HIV prevalence obtained from the EDHS in 2016 [12], which was 3.0%. Ethiopia achieved 67% of the expected overall UNAIDS target of 73% for the three targets. Achievements in the second and third 90s indicate that the country made considerable progress towards these targets. However, the gap in achievement was wider (11%) for the first 90 target. Based on the EPHIA HIV prevalence estimate and Ethiopia’s urban population size projected from the 2007 census for 2018 [15], it was estimated that there were approximately 384,000 adults living with HIV in urban Ethiopia. Approximately 303,000 of them were aware of their HIV-positive status, 295,000 were on treatment, and 258,000 achieved VLS. Among HIV-positive adults in EPHIA, 79% knew that they were HIV positive. This was similar to the awareness level estimated by another study in Ethiopia [20], but lower than the 2020 UNAIDS global estimate for eastern and southern Africa [4], which reported an awareness level of 87%. The PHIA surveys in several other countries [21] as well as other small-scale studies in Africa [22, 23] showed that countries in the continent were at various stages of progress towards achieving the first 90 target. Ethiopia was among those which performed relatively better [24], but still had gaps in achieving the first 90 or awareness target. Females were more likely to report that they knew their HIV-positive status than their male counterparts, which was consistent with findings from other studies [25-28]. Like what was reported by others from other sub-Saharan Africa (SSA) countries [28-31], we found that the PLHIV in the age group 15–24 were less likely to be aware of their HIV status. The challenge of reaching the youth in SSA for HIV testing was identified by some other studies as well [32]. As the youth constitutes a substantial segment of the population in Ethiopia [13], focusing on this group by the national programme can help to consolidate and improve the gains in HIV testing and, consequently, achieve treatment and VLS targets. Concurring with a report from Mozambique [25], awareness of HIV-positive status was also associated with condom use in the past 12 months in urban Ethiopia. This emphasizes the implications of high-risk sexual behaviours such as non-condom use and the associated unawareness of HIV-positive status would have for HIV programming. Given the low HIV prevalence and that the epidemic is concentrated in urban areas and as emphasized by others [33-35], Ethiopia needs to strengthen targeted testing by focusing on subgroups at higher risk based on behavioural, clinical, or demographic characteristics, including males, the youth, those with no formal education, and key and priority populations. Based on results from the EPHIA survey and other reports [36, 37], Ethiopia would need to address the considerable variability in awareness by administrative region, gender, and other social and behavioural determinants to enhance the enrolment of PLHIV in care and treatment services. Ethiopia’s performance in the second 90, though remarkable, was still short of achieving the UNAIDS target by 2020. Moreover, progress with this target may change as efforts to reach the first 90 target continue and ART coverage among those aware must be sustained. The UNAIDS global report 2019 indicated that, among people who knew their HIV status, 78% were accessing treatment [38]. The achievement varied by country [39] and Ethiopia was among those which performed well. Among HIV-positive adults who knew their HIV-positive status and were on treatment, 87.6% were virally suppressed, indicating that Ethiopia was close to achieving the 2020 VLS target. Indeed, this achievement was higher than the global average of 78%. However, VLS was as low as 74.3% among the youth posing a challenge that would need attention by the national HIV programme. VLS among adult men also remained behind, requiring due focus as two-thirds of all HIV transmissions were reported to be from adult men to women [40]. The importance of engaging the youth and adult men in care and treatment to ensure that they can maintain undetectable viral load has also been emphasized by other reports [32]. There is a need for giving focus to increasing awareness in the context of Ethiopia as most of the PLHIV who were not virally suppressed in EPHIA were unaware of their status. Unlike reports from other studies [41-43], age and gender were not significantly associated with VLS in the EPHIA survey. Interventions seeking to improve coverage of HIV testing, adherence, and retention in care to achieve VLS may require tailored programme components and strategies to increase awareness with an emphasis on the young population and men. The EPHIA results and data from other studies clearly indicate that Ethiopia should strengthen the HIV case identification and treatment programmes. Moreover, there is a consensus that without achieving the overarching target of the first 90, the control of the HIV epidemic will not be achieved [44]. Indeed, Ethiopia has recently taken the initiative of establishing an HIV case-based surveillance system to capture recent infections among newly diagnosed PLHIV and ensure that they receive the continuum of HIV care and treatment services and monitor individual and cluster-level outcomes as well as the country’s progress towards achieving the 95-95-95 targets. As emphasized by other reports [45, 46], it is essential to strengthen the health system to maintain the continued expansion of HIV services. Progress with the updated UNAIDS 95-95-95 targets is also being challenged by the COVID-19 pandemic [47], which has negatively impacted HIV services including testing and access to ART; a negative impact that is likely to continue even after the pandemic is controlled [48, 49]. It is suggested that the country, as in other similar settings [50], needs to step up its efforts to meet the challenges posed by the dual emergencies of HIV and COVID 19 epidemics.

Limitations

It should be noted that the EPHIA survey did not include the rural population, which could differ from the urban population with respect to HIV diagnosis, treatment, and VLS as well as participant characteristics and health facility readiness [51]. However, this could not be a major limitation as the survey covered the urban areas, where the epidemic in Ethiopia is concentrated. Some 6.4% of the eligible participants declined the interview and 5.1% eligible for laboratory specimens sampling declined blood draw. This could have introduced some bias, but this would not be substantial as the response rate was still much higher than the expected rate. The Somali region had a relatively small number of HIV-positive individuals and was excluded from the multivariate analysis. The survey did not include key populations such as commercial sex workers, which are high-risk groups considered as the major divers of the epidemic. The survey also had the inherent limitation of a cross-sectional study design, which does not allow for assessing causal relationships.

Conclusion

EPHIA provided scientifically sound evidence on the prevalence and status of UNAIDS 90-90-90 targets in urban Ethiopia. Our analysis showed that Ethiopia was on the verge of achieving the second and third 90s, but lagged behind in the first 90 target, and identified factors that negatively affected the program from achieving the targets. The national HIV care and treatment programme needs to target population groups with low access to HIV services such as men, the youth, and those with no education to improve awareness, treatment, and viral load suppression in urban Ethiopia. Achieving the first 90 target would require a continued effort to scale up HIV testing through innovative approaches such as self-testing and outreach community-friendly testing services with a special focus on high HIV burden geographic settings, the youth, men, and other high social risk groups living with HIV. Further exploratory research is needed to understand the role of the individual, community, and structural level barriers to achieving the updated interim 95-95-95 targets and identify the magnitude and determinants of outcome among the high-risk social groups. The EPHIA Study Team 3 Nov 2021
PONE-D-21-26375
Progress towards controlling the HIV epidemic in urban Ethiopia: Findings from the 2017-2018 Ethiopia population-based HIV impact assessment survey
PLOS ONE Dear Dr. Lulseged, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers agree on the significant contribution this work will make on HIV policy.  However, they have also both identified significant issues that must be addressed in order for this work to advance at PLOS ONE.  Importantly, I note that Reviewer #1 answered "No" to " Has the statistical analysis been performed appropriately and rigorously?" and Reviewer #2  answered "Partly" and "No" to the questions " Is the manuscript technically sound, and do the data support the conclusions?" and " Is the manuscript presented in an intelligible fashion and written in standard English?", respectively. At PLOS ONE, a "Yes" to each of these items is required.
 
While the authors must address all reviewer comments, I would like to draw special attention to the following issues.  Both reviewers found significant issues with grammar, sentence structure and typos and feel the manuscript requires a thorough copy-edit to improve clarity.  Reviewer #1 raises important concerns about the need for statistical analyses that include the simultaneous effects of multiple variables. The reviewers have both commented on the fact that the surveys focused on urban areas. While I agree that this may not be a major limitation (as Reviewer #1 feels), I do agree with Reviewer #2 that this fact should be introduced clearly and earlier in the manuscript so the reader can make their own assessment of this aspect. Please submit your revised manuscript by Dec 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, David Gerberry, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In the Methods section of your manuscript, please provide additional information regarding the criteria used to determine emancipation of minors. Furthermore, please could you clarify for minors ages between 15-18, who were not considered emancipated , whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent 3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information 4. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex 5. We note that Figure(s) Appendix 1, 2 and 3 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure Appendix 1, 2 and 3 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors analyzed data from the Ethiopian Population HIV Impact Assessment conducted in 2017/18 to assess the progress made towards attaining the UNAIDS- 90-90-90 targets and the associated socio-demographic and behavioural factors in Urban Ethiopia. They found that 79.0% of the respondents infected by HIV were aware of their HIV status based on self-report or detection of ARV metabolites; 97.1% of those aware, were on antiretroviral therapy; and of those on treatment, 87.6% had achieved viral suppression. Some disparities by population subgroups were found in achieving the first 90, while no disparities were found for the second and third 90 targets. The authors’ findings are informative and will guide program implementation efforts in urban areas in Ethiopia and in other countries in Sub Saharan Africa. I have the following general comments: 1. There are some typos in the abstract and in the main document, the authors may consider reading through carefully and correct them including sentence structure. I have highlighted some examples here below. 2. Analysis for the associated socio-demographic and behavioural factors have been limited to bivariate level, hence no consideration of simultaneous effect of multiple variables – which is a more realistic representation of our environments, the conclusions drawn here may not therefore be realistic to the real life situation. Additionally, the authors have previously published a paper “Factors associated with unawareness of HIV positive status in urban Ethiopia ….” in which the correct analysis approach was followed. 3. More detailed explanation of the survey design; field processes such as consenting of survey participants; and ethical considerations are already published in the survey report. The authors could focus more on analysis methods for the first and second objectives and in discussing the implication of the analysis results to program implementation. 4. In the appendices, figures/maps are presented but there is no description of analysis methods used and linkage to the objectives of the study. 5. Limitations, please add more. Focusing the survey in urban areas, I think may not qualify as a major limitation. The authors have rightly noted in the conclusions, these are the most affected sub areas which require more intensified efforts in the absence of adequate resources. 6. Methods of analysis is not explicitly stated in the methods section of the abstract. This will be helpful to link the results to the methods and the conclusions drawn. Additional specific comments - Line 63: “… however, with the end of 2020, ….” Review and revise the statement - Review and restate correctly the statement of targets. It does not read correct --Line 67: should read “…. 95% of PLHIV who know their status are on treatment” - Line 68: “…..have virally suppressed” replace with “…. have suppressed viral loads” - Line 181-182 “…62% did not use a condom the last sex …” change to “… 62% did not use a condom at last sex …” - In Table 1 “ first sex bonfire age 15” should read “First sex before age 15 years” - Line 205. “…among those aged 15-24…” should be “…. Among those aged 15-24 years…” - Repetition - line 195 and Line 196 (“…..had sex before age 15 (6.8%)…) - Line 309 “….receive….” is that supposed to be “….achieve...” - Table 2: missing “n” for viral suppression for the subgroup “did not use a condom” - Line 253: Is figure 5 (Appendix 1), prepared as part of this analysis or is reference? In either case, it needs to be clearly described in the methods section. Reviewer #2: The authors report findings of a large household survey conducted in urban areas of Ethiopia. The survey collected socio-demographic and behavioral indicators as well as self-reported HIV and treatment status information via questionnaires, and assessed HIV status, antiretroviral treatment (ART) use, and viral load suppression empirically based on blood samples from consenting participants. The authors report estimates of HIV prevalence, as well as proportions of people living with HIV who know their status, are on ART, and/or who are virally suppressed. These methods are consistent with other Population-based HIV Impact Assessment surveys done in sub-Saharan Africa, are sound, and provide data appropriate for these analyses. This manuscript is an important contribution to the research literature, as well as for understanding the HIV epidemic in urban areas of Ethiopia. I believe the manuscript itself would benefit from additional detail around the methods, and from copy-editing to improve clarity. I have discussed these in specific comments below. Major comments: 1. I would like to see more care that these results are not presented as nationally representative, e.g. at lines 32 and 47-49, given the urban scope of the survey. I appreciate that the urban scope is discussed as a limitation; please include the rationale for this choice in the Methods section as well. Line 88-89 (“a reliable nationally representative number of PLHIV for HIV programmatic planning was lacking”) draws particular attention to this limitation, so it would help to address it earlier. 2. The role of the weights in producing these estimates is not clear (e.g., line 141). Please provide a bit more detail about the survey design and what these weights account for. 3. There is a big drop-off from the 25,416 selected household members to the 21,560 considered eligible (Figure 1). Please elaborate on the eligibility criteria a bit more, and the potential limitations those might impose. For example, how many potential respondents were ineligible because they did not speak one of the survey languages (line 155), and might their exclusion have biased estimates? 4. In the results section and especially the figures and tables, please make sure the denominators are clear when looking at the “absolute” cascade (percentages of all PLHIV) vs. the “conditional” cascade (e.g. viral suppression among PLHIV on ART). 5. There are a couple places where it seems overly strong to claim that there are no differences in estimates, when differences in estimates apparently exist but perhaps did not reach statistical significance. For example, at line 228 the authors report that the “second 90 does not differ by age, gender, or administrative region”, but there are some numerical differences in these estimates in Table 2. This also applies to the third 90 at line 234-235. 6. The 97% ART coverage among PLHIV who know their status is praiseworthy, but I think it would be appropriate to temper the claim that the second 90 target has been achieved (Line 278). That situation may change as efforts to reach the first 90 target continue. The first two 90’s together would imply that at least 81% of PLHIV are on ART, in comparison to the 77% reported in Figure 1, which owes to the gap in achievement of the first 90. Efforts to maintain high ART coverage among those aware must be sustained as HIV status awareness improves. Minor comments: 1. Line 27: Missing punctuation before “some believed the targets were not achievable”? 2. Line 29-31: Perhaps the sentence starting “The overall cascade of HIV-positive people […]” should be in the Methods section. 3. Line 37: For context, it would help to list which ARVs were screened for in the methods section, and how those lined up with ARVs commonly in-use in Ethiopia when the survey was conducted. 4. Line 40-46: Please report uncertainty bounds about the estimates. 5. Line 42: “ARV” has not been defined. 6. Line 44-46: Since the 90-90-90 targets have not been formally defined in the preceding text, “variation in the achievement of the first 90 target” may be unclear to some readers. Please either define the three components of the 90-90-90 targets or describe this more directly ("variation in knowledge of HIV-positive status"). 7. Line 55: “United Nations Programme of HIV/AIDS” should be “the Joint United Nations Programme on HIV/AIDS” as at line 25. 8. Line 71-82: Please check the references in this section. For example, reference (8) pertains to TB and does not seem to support the claims here regarding declines in HIV incidence and mortality. 9. Line 81-82: The sentence starting “Treatment failure[…]” seems a bit disconnected from the rest of the paragraph. 10. Line 96: “countries” should be “country’s” 11. Line 114: Please clarify whether these eleven regions refer to the nine regional states and two city administrations? 12. Line 139: Please close or remove the unmatched parentheses here and throughout the text and tables. 13. Line 170: Please define “EA”. 14. Table 1: (a) There seems to be a typo for the total HIV-negative by sex (n=46205). (b) Should “First sex bonfire age 15” be “First sex before age 15”? 15. Figure 2: (a) There should not be confidence intervals on the UNAIDS targets. (b) Please lighten the bar color for the survey-based estimates, as the lower limits of the uncertainty bounds are barely visible. 16. Table 2: The sample size for viral suppression among those who did not use a condom is missing. 17. Line 231: Should “condom use in the last 24 hours” be “condom use at last sex in the last 12 months”? 18. Figures 5-7: I believe these estimates come from different time points? Please clarify. 19. Line 287-88: “[…]two-thirds of all HIV transmissions were estimated to be from adult men to women.” Please provide a citation for this. 20. I spotted a couple issues in the references, please review: (a) Line 354: The title is incorrect. (b) Line 416: The author (UNAIDS) is garbled. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Robert Glaubius [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
7 Dec 2021 Completed uploading Submitted filename: Response to Reviewers.docx Click here for additional data file. 21 Jan 2022
PONE-D-21-26375R1
Progress towards controlling the HIV epidemic in urban Ethiopia: Findings from the 2017-2018 Ethiopia population-based HIV impact assessment survey
PLOS ONE Dear Dr. Lulseged, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not yet fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Both reviewers have responded favorably to the changes made in Revision #1.  The article seems on its way toward publication in PLOS ONE.  All that remains is to address the remaining concerns of Reviewer #2. Provided that these primarily straightforward concerns are addressed in the next version, I do not anticipate needing to send the article back out to the reviewers. Please submit your revised manuscript by Mar 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, David Gerberry, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The Authors have now applied a more appropriate statistical analysis methodology, presented and explained the results well to my satisfaction. The explanations are now clearer and easy to follow. Reviewer #2: The authors have largely addressed each of my comments. Most of my comments below are on copy-editing issues rather than methodological concerns, though I do have some questions regarding the new multivariate regression analysis. 1. I appreciate that the authors are now more explicit about "unconditional" and "conditional" estimates and targets. These terms should be defined in the methods section, or replaced with more direct statements, as has been done in Table 3 (e.g. "Virally suppressed among HIV+ participants on ART"). 2. I also appreciate the new multivariate regression analysis. I answered "I don't know" with regards to the appropriateness and rigor of the approach because I feel we need a bit more information here. Could you please explain how you chose which explanatory variables to include? Was age modeled as a continuous variable or a categorical variable? Either is valid, but if modeled categorically, that might have diluted any age effects so it seems worth mentioning. Finally, Table 3 includes education level but Table 2 does not. Could that be added to Table 2 to provide more context? 3. Please review Table 1 carefully for accuracy and clarity: 3.a. Total rows for administrative region and sex incorrectly state the 95% CI for HIV prevalence as ".8-3.3"; this is reported as "2.8-3.3" at line 218. 3.b. Under "First sex before age 15", percentages HIV-positive and HIV-negative are missing. 3.c. HIV prevalence among those never tested cannot be right, "1 9 (0.7-1.3)", if 99.0% of those never tested were HIV-negative. 3.d. The 95% CI for the % of never-tested who were HIV-negative seems far too wide (8.7-99.0). 3.e. There are several typos, like square brackets sometimes used in place of parentheses, duplicate parentheses ("))"), and inconsistent use of commas and percentage signs. These may be minor individually, but together suggest that there could be other undetected errors in the results too. 4. The authors have improved many of the copy-editing issues identified in the previous round, but there are some issues remaining: 4.a. Line 42: "Awareness Females about HIV-positive[...]" perhaps should be "Awareness of HIV-positive status[...]"? 4.b. Lines 166-168 repeat lines 97-99; these could be merged. 4.c. Line 194-201: The paragraph duplicates the number eligible among household members identified (lines 192 & 195) and interviewed among eligible (lines 195 & 199). Perhaps this paragraph could be revised to eliminate redundancy? 4.d. Line 207: "[...]34.9% were 1 in the[...]". Please remove "1". 4.e. Line 223: "[...]and food-insecure 95% CI (5.0% [95% CI: 3.7-6.8])". Please remove the first "95% CI". 4.f. Line 223-224: "[...]than the categories[...]" should be "[...]than in the other categories[...]" 4.g. Line 233: Please consider changing "77% of them on ART" to "77% were on ART" 4.h. Line 233: Please consider changing "had viral suppression" to "were virally suppressed" or "had suppressed viral loads". 4.i. Line 246: You might change "[...]adjusted for ARV detection." to "[...]when adjusted for ARV detection." 4.j. Line 266: I think this is missing a period, and perhaps there should not be a paragraph break here? 4.k. Figure 4: You might remove "based on ARV" since the caption states that these estimates are ARV-adjusted. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Joseph Ouma Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: Comments_ICAP Ethopia.pdf Click here for additional data file. 31 Jan 2022 All the responses are included in rebuttal letter Submitted filename: Response to Reviewers.docx Click here for additional data file. 11 Feb 2022 Progress towards controlling the HIV epidemic in urban Ethiopia: Findings from the 2017-2018 Ethiopia population-based HIV impact assessment survey PONE-D-21-26375R2 Dear Dr. Lulseged, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, David Gerberry, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 16 Feb 2022 PONE-D-21-26375R2 Progress towards controlling the HIV epidemic in urban Ethiopia: Findings from the 2017-2018 Ethiopia population-based HIV impact assessment survey Dear Dr. Lulseged: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. David Gerberry Academic Editor PLOS ONE
Yimam Getaneh (PI)Saro AbdellaWudinesh BeleteTsigereda KifleAbebe HabteselassieMinilik DemissieG/medhin G/MichaelHabtamu TeklieEbba AbateEthiopian Public Health Institute
Eleni SeyoumFederal HIV/AIDS Prevention and Control Office
Esayas MuletaCentral Statistics Agency
Frehywot EshetuJelaludin AhmedClare DykewiczAshenafi HaileYared TedlaJeff HansonChristine RossBiniyam EskinderSolomon FekadieWondimu TeferiU.S Centers for Disease Control and Prevention, Ethiopia
Drew Voetsch (PI)Aderonke S. AjiboyeSehin BirhanuKristin BrownEdith NyangomaBharat ParekhHetal PateChristine W. WestU.S Centers for Disease Control and Prevention, Atlanta
Sileshi Lulseged (PI)Zenebe MelakuHalegnaw EsheteTerefe GeliboBelete TegbaruYohanes DemissieNadew TademeICAP-Columbia University, Ethiopia
Jessica Justman (PI)David HoosMansoor FarahaniKarampreet SachathepSuzue SaitoAndrea LowChelsea SolmoICAP-Columbia University-New York
  32 in total

1.  Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.

Authors:  Tendani Gaolathe; Kathleen E Wirth; Molly Pretorius Holme; Joseph Makhema; Sikhulile Moyo; Unoda Chakalisa; Etienne Kadima Yankinda; Quanhong Lei; Mompati Mmalane; Vlad Novitsky; Lillian Okui; Erik van Widenfelt; Kathleen M Powis; Nealia Khan; Kara Bennett; Hermann Bussmann; Scott Dryden-Peterson; Refeletswe Lebelonyane; Shenaaz El-Halabi; Lisa A Mills; Tafireyi Marukutira; Rui Wang; Eric J Tchetgen Tchetgen; Victor DeGruttola; M Essex; Shahin Lockman
Journal:  Lancet HIV       Date:  2016-03-24       Impact factor: 12.767

2.  Understating the barriers to achievement of the UNAIDS 90-90-90 goal in Tanzania using a population-based HIV impact assessment survey 2016-2017.

Authors:  Yan Wang; Sylvia Kiwuwa-Muyingo; Damazo T Kadengye
Journal:  AIDS Care       Date:  2021-05-11

3.  Predictors of HIV Testing among Youth in Sub-Saharan Africa: A Cross-Sectional Study.

Authors:  Ibitola O Asaolu; Jayleen K Gunn; Katherine E Center; Mary P Koss; Juliet I Iwelunmor; John E Ehiri
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

4.  Higher risk sexual behaviour is associated with unawareness of HIV-positivity and lack of viral suppression - implications for Treatment as Prevention.

Authors:  Helena Huerga; Emilie Venables; Jihane Ben-Farhat; Gilles van Cutsem; Tom Ellman; Chris Kenyon
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

5.  Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades.

Authors:  Jacob Levi; Alice Raymond; Anton Pozniak; Pietro Vernazza; Philipp Kohler; Andrew Hill
Journal:  BMJ Glob Health       Date:  2016-09-15

Review 6.  The Impact of COVID-19 on HIV Treatment and Research: A Call to Action.

Authors:  Tiffany Chenneville; Kemesha Gabbidon; Patricia Hanson; Cashea Holyfield
Journal:  Int J Environ Res Public Health       Date:  2020-06-24       Impact factor: 3.390

7.  Awareness of HIV status, prevention knowledge and condom use among people living with HIV in Mozambique.

Authors:  E Kainne Dokubo; Ray W Shiraishi; Peter W Young; Joyce J Neal; John Aberle-Grasse; Nely Honwana; Francisco Mbofana
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

8.  Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.

Authors:  Demewoz Haile; Abulie Takele; Ketema Gashaw; Habtamu Demelash; Dabere Nigatu
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

9.  Is home-based HIV testing universally acceptable? Findings from a case-control study nested within the HPTN 071 (PopART) trial.

Authors:  K Sabapathy; C Mulubwa; H Mathema; C Mubekapi-Musadaidzwa; A Schaap; G Hoddinott; J Hargreaves; S Floyd; H Ayles; R Hayes
Journal:  Trop Med Int Health       Date:  2018-04-16       Impact factor: 2.622

10.  Trends and spatial distributions of HIV prevalence in Ethiopia.

Authors:  Getiye Dejenu Kibret; Aster Ferede; Cheru Tesema Leshargie; Fasil Wagnew; Daniel Bekele Ketema; Animut Alebel
Journal:  Infect Dis Poverty       Date:  2019-10-17       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.